3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide

C49H44N18O5 — CID 157147876

IUPAC3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide
SMILESCC(C(=O)Cc1ccccn1)(c1ccccc1)n1ncc2c1nc(N)n1nc(-c3ccco3)nc21.Cc1nccnc1-c1nc2c3cnn(C(C)(C(=O)NCC4(O)COC4)c4ccccc4)c3nc(N)n2n1
InChIInChI=1S/C25H20N8O2.C24H24N10O3/c1-25(16-8-3-2-4-9-16,20(34)14-17-10-5-6-12-27-17)33-23-18(15-28-33)22-29-21(19-11-7-13-35-19)31-32(22)24(26)30-23;1-14-17(27-9-8-26-14)18-30-19-16-10-29-34(20(16)31-22(25)33(19)32-18)23(2,15-6-4-3-5-7-15)21(35)28-11-24(36)12-37-13-24/h2-13,15H,14H2,1H3,(H2,26,30);3-10,36H,11-13H2,1-2H3,(H2,25,31)(H,28,35)
InChIKeyAKXJBEOZCGCNGV-UHFFFAOYSA-N
MW965.01 g/mol
LogP3.75
Rot. Bonds12

About 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide

3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide (PubChem CID 157147876) has the molecular formula C49H44N18O5 and a molecular weight of 965.01 g/mol. Its IUPAC name is 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide.

Molecular Properties

Compound Name3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide
PubChem CID157147876
Molecular FormulaC49H44N18O5
Molecular Weight965.01 g/mol
Exact Mass964.37
IUPAC Name3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide
SMILESCC(C(=O)Cc1ccccn1)(c1ccccc1)n1ncc2c1nc(N)n1nc(-c3ccco3)nc21.Cc1nccnc1-c1nc2c3cnn(C(C)(C(=O)NCC4(O)COC4)c4ccccc4)c3nc(N)n2n1
InChIInChI=1S/C25H20N8O2.C24H24N10O3/c1-25(16-8-3-2-4-9-16,20(34)14-17-10-5-6-12-27-17)33-23-18(15-28-33)22-29-21(19-11-7-13-35-19)31-32(22)24(26)30-23;1-14-17(27-9-8-26-14)18-30-19-16-10-29-34(20(16)31-22(25)33(19)32-18)23(2,15-6-4-3-5-7-15)21(35)28-11-24(36)12-37-13-24/h2-13,15H,14H2,1H3,(H2,26,30);3-10,36H,11-13H2,1-2H3,(H2,25,31)(H,28,35)
InChIKeyAKXJBEOZCGCNGV-UHFFFAOYSA-N
XLogP3.75
TPSA301.28 Ų
H-Bond Donors4
H-Bond Acceptors22
Rotatable Bonds12
Heavy Atoms72
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500965.01
LogP ≤ 53.75
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1022

Analyze 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide?
The IUPAC name of 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide (CID 157147876) is 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide.
What is the SMILES notation for 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide?
The canonical SMILES for 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide is CC(C(=O)Cc1ccccn1)(c1ccccc1)n1ncc2c1nc(N)n1nc(-c3ccco3)nc21.Cc1nccnc1-c1nc2c3cnn(C(C)(C(=O)NCC4(O)COC4)c4ccccc4)c3nc(N)n2n1.
What is the InChIKey of 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide?
The InChIKey is AKXJBEOZCGCNGV-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H20N8O2.C24H24N10O3/c1-25(16-8-3-2-4-9-16,20(34)14-17-10-5-6-12-27-17)33-23-18(15-28-33)22-29-21(19-11-7-13-35-19)31-32(22)24(26)30-23;1-14-17(27-9-8-26-14)18-30-19-16-10-29-34(20(16)31-22(25)33(19)32-18)23(2,15-6-4-3-5-7-15)21(35)28-11-24(36)12-37-13-24/h2-13,15H,14H2,1H3,(H2,26,30);3-10,36H,11-13H2,1-2H3,(H2,25,31)(H,28,35).
What are the key properties of 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide?
3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide has a molecular weight of 965.01 g/mol, XLogP of 3.75, 12 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-3-phenyl-1-pyridin-2-ylbutan-2-one;2-[7-amino-4-(3-methylpyrazin-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]-N-[(3-hydroxyoxetan-3-yl)methyl]-2-phenylpropanamide is sourced from PubChem (CID 157147876), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).